Reagan Kakande, Victor Adejayan, Muhammad Zulfiqar, Michael Ndyomugabe, Phoebe Gruccio, Philemon Ojuman, William S Girard, Rinah Arinaitwe, Mark Conaway, Eva Otoupalova, Christopher C Moore, Edwin Nuwagira
{"title":"乌干达姆巴拉拉地区转诊医院接受皮质类固醇治疗的脓毒症成人急诊病房患者的特征和结局","authors":"Reagan Kakande, Victor Adejayan, Muhammad Zulfiqar, Michael Ndyomugabe, Phoebe Gruccio, Philemon Ojuman, William S Girard, Rinah Arinaitwe, Mark Conaway, Eva Otoupalova, Christopher C Moore, Edwin Nuwagira","doi":"10.1136/emermed-2025-214957","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Corticosteroids are recommended for the treatment of septic shock but are understudied in Africa. We aimed to determine (1) characteristics of patients with sepsis in Uganda who received corticosteroids, and (2) the association between receiving corticosteroids and outcomes.</p><p><strong>Methods: </strong>We conducted a single centre retrospective observational cohort study of patients with sepsis at the Mbarara Regional Referral Hospital in Uganda. We included patients admitted from the emergency ward with suspected infection and ≥2 quick sequential organ failure assessment criteria. We determined predictors of receiving corticosteroids with logistic regression and predictors of 28-day mortality using Cox proportional hazards regression. We adjusted models for severity of illness using the Universal Vital Assessment (UVA) mortality risk score.</p><p><strong>Results: </strong>Of the 300 patients analysed, 141 (47%) were female, and the median (IQR) age was 55 (43-66) years. Corticosteroids were received by 71 (23%) patients at a median (IQR) of 1 (0-2) day from admission. The UVA score (adjusted OR (aOR) 1.16, 95% CI 1.03 to 1.30) and meningitis (aOR 4.31, 95% CI 2.04 to 9.12) were predictors of receiving corticosteroids. The UVA score (adjusted HR (aHR) 1.14, 95% CI 1.02 to 1.26) and receiving corticosteroids (aHR 0.43, 95% CI 0.21 to 0.91) were predictors of increased and decreased 28-day mortality, respectively. Receiving corticosteroids remained an independent predictor of decreased 28-day mortality when entered into the model as a time dependent variable (aHR 0.33, 95% CI 0.13 to 0.83, p=0.02). In a sensitivity analysis adjusted for age, sex and severity of illness, receiving vasopressors (aHR 3.48, 95% CI 1.88 to 6.43, p<0.001) and receiving corticosteroids (aHR 0.40, 95% CI 0.19 to 0.85, p=0.02) were independent predictors of increased and decreased 28-day mortality, respectively.</p><p><strong>Conclusions: </strong>In patients with sepsis in Uganda, receiving corticosteroids was associated with severity of illness and meningitis, and receiving corticosteroids was associated with improved outcomes.</p>","PeriodicalId":11532,"journal":{"name":"Emergency Medicine Journal","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Characteristics and outcomes of adult emergency ward patients with sepsis who received corticosteroids at the Mbarara Regional Referral Hospital in Uganda.\",\"authors\":\"Reagan Kakande, Victor Adejayan, Muhammad Zulfiqar, Michael Ndyomugabe, Phoebe Gruccio, Philemon Ojuman, William S Girard, Rinah Arinaitwe, Mark Conaway, Eva Otoupalova, Christopher C Moore, Edwin Nuwagira\",\"doi\":\"10.1136/emermed-2025-214957\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Corticosteroids are recommended for the treatment of septic shock but are understudied in Africa. We aimed to determine (1) characteristics of patients with sepsis in Uganda who received corticosteroids, and (2) the association between receiving corticosteroids and outcomes.</p><p><strong>Methods: </strong>We conducted a single centre retrospective observational cohort study of patients with sepsis at the Mbarara Regional Referral Hospital in Uganda. We included patients admitted from the emergency ward with suspected infection and ≥2 quick sequential organ failure assessment criteria. We determined predictors of receiving corticosteroids with logistic regression and predictors of 28-day mortality using Cox proportional hazards regression. We adjusted models for severity of illness using the Universal Vital Assessment (UVA) mortality risk score.</p><p><strong>Results: </strong>Of the 300 patients analysed, 141 (47%) were female, and the median (IQR) age was 55 (43-66) years. Corticosteroids were received by 71 (23%) patients at a median (IQR) of 1 (0-2) day from admission. The UVA score (adjusted OR (aOR) 1.16, 95% CI 1.03 to 1.30) and meningitis (aOR 4.31, 95% CI 2.04 to 9.12) were predictors of receiving corticosteroids. The UVA score (adjusted HR (aHR) 1.14, 95% CI 1.02 to 1.26) and receiving corticosteroids (aHR 0.43, 95% CI 0.21 to 0.91) were predictors of increased and decreased 28-day mortality, respectively. Receiving corticosteroids remained an independent predictor of decreased 28-day mortality when entered into the model as a time dependent variable (aHR 0.33, 95% CI 0.13 to 0.83, p=0.02). In a sensitivity analysis adjusted for age, sex and severity of illness, receiving vasopressors (aHR 3.48, 95% CI 1.88 to 6.43, p<0.001) and receiving corticosteroids (aHR 0.40, 95% CI 0.19 to 0.85, p=0.02) were independent predictors of increased and decreased 28-day mortality, respectively.</p><p><strong>Conclusions: </strong>In patients with sepsis in Uganda, receiving corticosteroids was associated with severity of illness and meningitis, and receiving corticosteroids was associated with improved outcomes.</p>\",\"PeriodicalId\":11532,\"journal\":{\"name\":\"Emergency Medicine Journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-10-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Emergency Medicine Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/emermed-2025-214957\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"EMERGENCY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emergency Medicine Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/emermed-2025-214957","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"EMERGENCY MEDICINE","Score":null,"Total":0}
引用次数: 0
摘要
背景:皮质类固醇被推荐用于感染性休克的治疗,但在非洲研究不足。我们的目的是确定(1)乌干达接受糖皮质激素治疗的脓毒症患者的特征,以及(2)接受糖皮质激素治疗与预后之间的关系。方法:我们对乌干达姆巴拉拉地区转诊医院脓毒症患者进行了一项单中心回顾性观察队列研究。我们纳入了疑似感染且≥2个快速序贯器官衰竭评估标准的急诊病房入院患者。我们用逻辑回归确定了接受皮质类固醇治疗的预测因子,用Cox比例风险回归确定了28天死亡率的预测因子。我们使用通用生命评估(UVA)死亡率风险评分来调整疾病严重程度的模型。结果:300例患者中,141例(47%)为女性,中位(IQR)年龄为55(43-66)岁。71例(23%)患者在入院后1(0-2)天的中位(IQR)时间内接受了皮质类固醇治疗。UVA评分(调整OR (aOR) 1.16, 95% CI 1.03 ~ 1.30)和脑膜炎(aOR 4.31, 95% CI 2.04 ~ 9.12)是接受皮质类固醇治疗的预测因子。UVA评分(调整HR (aHR) 1.14, 95% CI 1.02 ~ 1.26)和接受皮质类固醇(aHR 0.43, 95% CI 0.21 ~ 0.91)分别是28天死亡率升高和降低的预测因子。当作为时间相关变量进入模型时,接受皮质类固醇仍然是降低28天死亡率的独立预测因子(aHR 0.33, 95% CI 0.13至0.83,p=0.02)。在一项针对年龄、性别和疾病严重程度进行调整的敏感性分析中,接受血管加压药(aHR 3.48, 95% CI 1.88至6.43)的结论:在乌干达的脓毒症患者中,接受皮质类固醇与疾病严重程度和脑膜炎相关,接受皮质类固醇与改善预后相关。
Characteristics and outcomes of adult emergency ward patients with sepsis who received corticosteroids at the Mbarara Regional Referral Hospital in Uganda.
Background: Corticosteroids are recommended for the treatment of septic shock but are understudied in Africa. We aimed to determine (1) characteristics of patients with sepsis in Uganda who received corticosteroids, and (2) the association between receiving corticosteroids and outcomes.
Methods: We conducted a single centre retrospective observational cohort study of patients with sepsis at the Mbarara Regional Referral Hospital in Uganda. We included patients admitted from the emergency ward with suspected infection and ≥2 quick sequential organ failure assessment criteria. We determined predictors of receiving corticosteroids with logistic regression and predictors of 28-day mortality using Cox proportional hazards regression. We adjusted models for severity of illness using the Universal Vital Assessment (UVA) mortality risk score.
Results: Of the 300 patients analysed, 141 (47%) were female, and the median (IQR) age was 55 (43-66) years. Corticosteroids were received by 71 (23%) patients at a median (IQR) of 1 (0-2) day from admission. The UVA score (adjusted OR (aOR) 1.16, 95% CI 1.03 to 1.30) and meningitis (aOR 4.31, 95% CI 2.04 to 9.12) were predictors of receiving corticosteroids. The UVA score (adjusted HR (aHR) 1.14, 95% CI 1.02 to 1.26) and receiving corticosteroids (aHR 0.43, 95% CI 0.21 to 0.91) were predictors of increased and decreased 28-day mortality, respectively. Receiving corticosteroids remained an independent predictor of decreased 28-day mortality when entered into the model as a time dependent variable (aHR 0.33, 95% CI 0.13 to 0.83, p=0.02). In a sensitivity analysis adjusted for age, sex and severity of illness, receiving vasopressors (aHR 3.48, 95% CI 1.88 to 6.43, p<0.001) and receiving corticosteroids (aHR 0.40, 95% CI 0.19 to 0.85, p=0.02) were independent predictors of increased and decreased 28-day mortality, respectively.
Conclusions: In patients with sepsis in Uganda, receiving corticosteroids was associated with severity of illness and meningitis, and receiving corticosteroids was associated with improved outcomes.
期刊介绍:
The Emergency Medicine Journal is a leading international journal reporting developments and advances in emergency medicine and acute care. It has relevance to all specialties involved in the management of emergencies in the hospital and prehospital environment. Each issue contains editorials, reviews, original research, evidence based reviews, letters and more.